/
/
/

Suven Life Sciences Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)282.05
Volume (₹)6.73 L
High (₹)285.00
Upper Circuit331.30
Low (₹)266.05
Lower Circuit220.90
Prev Close276.10
52W High (₹)403.35
Price276.10
52W Low (₹)124.11

Share Market Cap & Key Ratios Overview

M.Cap (₹)7802.97 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.00
Price to Book8.07
Book Value16.46
EPS (TTM)-12.47
Face Value1.00
ROE (%)-101.81

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
SUVENNSE
LTP
1W Low
1W High
Market cap (₹)
1829+51.3 (2.89%)
1722
1839.70
4,26,122Cr
10140.5+360.5 (3.69%)
9863
10159
2,66,424Cr
4710+96.6 (2.09%)
4553
4753.40
1,79,914Cr
2346-59.5 (-2.47%)
2252.40
2441.90
1,24,601Cr
1193-52.5 (-4.22%)
1172
1266.60
1,18,703Cr
1366+14 (1.04%)
1336.70
1384
1,14,599Cr
1404.1+25.2 (1.83%)
1364.60
1408
1,13,112Cr
2518+25.2 (1.01%)
2457.90
2561.20
1,04,631Cr
1785+103.6 (6.16%)
1656.20
1796.80
97,878Cr
1988-23 (-1.14%)
1944.10
2062.10
92,145Cr
276.1+17.25 (6.66%)
256.30
285
7,803Cr

Key Highlights of Suven Life Sciences Ltd Balance Sheet

Suven Life Sciences Ltd balance sheet discloses shareholders' funds of ₹26.37Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹26.37Cr, and the reserves and surplus of the company is ₹1319.77Cr.

The company has its non-current liabilities with total liabilities of ₹1531.06Cr as of 2026-03-31.

The current liabilities are ₹13.63Cr as of 2026-03-31. At the same time, current assets are ₹540.71Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹912.85Cr and tangible assets of ₹73Cr, provided in the Suven Life Sciences Ltd financial statements.